Critics of the Trans-Pacific Partnership (TPP) have voiced dire warnings that the 12-country deal would have a negative effect on medication prices and access for not only millions of Americans, but also those in developing countries. RT’s Lindsay France speaks with Peter Maybarduk, director of Public Citizen’s Global Access to Medicines Program, to get a broader view of the TPP’s impact.